ALNY

Alnylam Pharmaceuticals Inc

May 18 • 04:00PM ET

286.27

-0.71 -0.25 %

Healthcare • Biotechnology • USA • Large • NASD

Peers: ARWR SRPT BMRN RARE REGN VRTX MRNA BNTX UTHR EXEL

| Held by: VTI VO QQQ VUG VXF VOT IBB IWP CGGR QQQM

Scroll to Statements

Index	NDX	P/E	68.02	EPS (ttm)	4.21	Insider Own	0.69%	Shs Outstand	133.44M	Perf Week	0.50%
Market Cap	38.22B	Forward P/E	26.89	EPS next Y	10.65	Insider Trans	-8.75%	Shs Float	132.59M	Perf Month	-7.55%
Enterprise Value	38.18B	PEG	0.34	EPS next Q	1.61	Inst Own	98.57%	Short Float	3.60%	Perf Quarter	-13.93%
Income	577.22M	P/S	8.92	EPS this Y	217.25%	Inst Trans	-1.62%	Short Ratio	4.28	Perf Half Y	-36.94%
Sales	4.29B	P/B	35.52	EPS next Y	44.02%	ROA	12.36%	Short Interest	4.77M	Perf YTD	-28.01%
Book/sh	8.06	P/C	12.70	EPS next 5Y	78.62%	ROE	96.94%	52W High	495.55 -42.23%	Perf Year	0.34%
Cash/sh	22.54	P/FCF	59.59	EPS past 3/5Y	- -	ROIC	15.30%	52W Low	280.60 2.02%	Perf 3Y	50.77%
Dividend Est.	-	EV/EBITDA	47.32	Sales past 3/5Y	52.98% 49.77%	Gross Margin	80.83%	Volatility	3.23% 3.52%	Perf 5Y	111.82%
Dividend TTM	-	EV/Sales	8.91	EPS Y/Y TTM	308.45%	Oper. Margin	17.54%	ATR (14)	10.92	Perf 10Y	426.81%
Dividend Ex-Date	-	Quick Ratio	3.06	Sales Y/Y TTM	82.57%	Profit Margin	13.46%	RSI (14)	37.46	Recom	1.73
Dividend Gr. 3/5Y	- -	Current Ratio	3.13	EPS Q/Q	440.32%	SMA20	-4.32%	Beta	0.29	Target Price	442.52
Payout	0.00%	Debt/Eq	2.76	Sales Q/Q	96.43%	SMA50	-8.30%	Rel Volume	0.78	Prev Close	286.98
Employees	2500	LT Debt/Eq	2.51	Earnings	Apr 30 BMO	SMA200	-26.74%	Avg Volume	1.12M	Price	286.27
IPO	May 28, 2004	Option/Short	Yes / Yes	EPS/Sales Surpr.	73.26% 4.63%	Trades		Volume	873,361	Change	-0.25%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)